l‐Carnitine relieves cachexia‐related skeletal muscle fibrosis by inducing deltex E3 ubiquitin ligase 3L to negatively regulate the Runx2/COL1A1 axis

Documenti analoghi

• Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
  di: Marianne J. Hjermstad, et al.
  Pubblicazione: (2024)
• Hydrogen sulfide inhibits skeletal muscle ageing by up‐regulating autophagy through promoting deubiquitination of adenosine 5’‐monophosphate (AMP)‐activated protein kinase α1 via ubiquitin specific peptidase 5
  di: Jia‐He Yang, et al.
  Pubblicazione: (2024)
• CREG1 deficiency impaired myoblast differentiation and skeletal muscle regeneration
  di: Haixu Song, et al.
  Pubblicazione: (2024)
• Metabolomics‐driven discovery of therapeutic targets for cancer cachexia
  di: Pengfei Cui, et al.
  Pubblicazione: (2024)
• Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
  di: Michael S. Yule, et al.
  Pubblicazione: (2024)